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ABSTRACT
To investigate the expressional alternation of microRNAs (miRNA) during the malignant transformation and development of human glioma,
wemeasuredmiRNA expression proﬁle aswell asmRNA expression proﬁle in normal human neural stem cells (hNSCs) and human glioma stem
cells (hGSCs). We found 116 miRNA up-regulated and 62 miRNA down-regulated in GSCs. On the other hand, we identiﬁed 1,372 mRNA
down-regulated, and 1,501 mRNA up-regulated in GSCs compared to those in NSCs. We then analyzed the pathways and the predicted target
genes of the miRNAs which differ signiﬁcantly in expression between GSCs and NSCs using the statistical enrichment methods. These target
mRNAs are involved in many cancer-related signaling pathways, such as cell cycle, axon guidance, glioma development, adhesion junction,
MAPK and Wnt signaling. Furthermore, we obtained the differently expressed miRNA-target relationships according to the u value which is
used to calculate the regulation extent of miRNA-target and using the databases of miRanda, Targetscans and Pictar. Among the top 10
miRNA-target relationships, hsa-miR-198 and its potential targeted gene DCX and NNATwere selected for validation, and NNATwas found to
be the direct target of miR-198. Finally, the functional roles of miR-155–5p and miR-124–3p whose expressions altered signiﬁcantly between
GSCs and NSCs were addressed. Our results provide new clues for the potential mechanisms involved in the origin and development of glioma.
Clinically, the altered miRNAs may serve as potential targets and diagnostic tools for novel therapeutic strategies of glioblastoma. J. Cell.
Biochem. 115: 1368–1380, 2014. © 2014 Wiley Periodicals, Inc.
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Malignant gliomas are the most common and deadly primarybrain tumors in adults [Maher et al., 2001]. Although there
is much progress in surgery, radiotherapy and chemotherapy for the
management of this disease, the prognosis of malignant glioma is
still poor. The median survival time for glioblastoma (GBM) is
14 months [Maher et al., 2001]. The indistinct knowledge about the
origin of glioma limits the technique development for their therapy.
Recent studies of human brain tumors have shown that there is a
small group of cell types that have the ability to regenerate
themselves and are resistant to radiotherapy and chemotherapy.
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These cells are brain tumor stem cell (BTSC) enriched [Singh
et al., 2004; Galli et al., 2004; Dean et al., 2005; Rich et al., 2007]. The
BTSCs have shown many characteristics in common with neural
stem cells (NSCs), such as self-renewal and multi-potential
differentiation. It was supposed that BTSCs might originate from
mutant NSCs [Calabrese et al., 2007; Quinones et al., 2007;
Chaichana et al., 2009]. Elucidating the genetic circuits that govern
the malignant transformation from NSCs to GSCs is essential to
understanding the origin of brain tumors and to the development of
novel therapeutic strategies for malignant glioma. Extensive efforts
have been made to determine such regulatory circuits through the
proﬁling of messenger RNA (mRNA) in glioma tissues [Pragathi
et al., 2010; Dinorah et al., 2012; Katz et al., 2012; Leone et al., 2012].
However, since mRNA proﬁles largely reﬂect the consequences of
transcriptional regulation, these studies do not fully take into
account the extensive post-transcriptional programs that control the
NSC malignant transformation and the glioma origin, particularly
those programs that are controlled by an abundant class of
noncoding RNAs, the microRNAs (miRNAs).
MiRNAs are a species of small, noncoding, single-stranded RNA
molecules (19–22 nucleotides) that repress translation or initiate
transcript degradation by imperfect base pairing with cognate target
mRNAs [Bartel et al., 2009]. In sum, more than half of the human
protein-coding genes appear to have been under selective pressure to
maintain 30-UTR pairing to miRNAs [Friedman et al., 2008]. Each
miRNA can potentially regulate several hundred-target genes [Bartel
et al., 2009; Friedman et al., 2009]. Thus, miRNA-mediated gene
regulation may have profound effects on gene expression. They are
implicated in several biological processes, including development,
proliferation, differentiation, apoptosis, and pathogenesis of cancer
cells [Bartel et al., 2004; Berezikov et al., 2005; Hwang et al., 2006].
Different miRNAs may function as either tumor suppressors or
oncogenes, and the deregulation of their expression is associated
with the initiation and progression of cancer [Croce et al., 2009].
While the origin of gliomas is largely unknown, there is increasing
speculation that they may arise from glioma stem cells (GSCs) that
are transformed from NSCs [Calabrese et al., 2007; Quinones et al.,
2007; Chaichana et al., 2009]. Several recent studies have revealed
that miRNA regulates various aspects of GSCs biology [Zhu
et al., 2005; Kesari et al., 2006; Piccirillo et al., 2006; Sherry
et al., 2009; Chan et al., 2012; Ying et al., 2012]. However, few studies
have been carried out to clarify the regulatory roles of miRNA in the
malignant transition of NSCs to BTSCs, or GSCs.
In this study we conducted a genome-widemiRNA expression study
(1665 human microRNA probes) and mRNA expression study (29,186
humanmRNAprobes) in normalNSCs andadultGSCs to ensure a broad
proﬁling among cellular miRNAs and mRNAs. Then, we investigated
themiRNAprograms thatmaymark the transition of NSCs toGSCs and
identiﬁed several key pathways involved in this transition.
MATERIALS AND METHODS
HUMAN NSC ISOLATION AND PRIMARY CULTURE
Human NSCs were obtained from the hippocampus of three 12-week
male fetuses of spontaneous abortion. They were cultured in vitro by
the procedures that were previously described [Liu et al., 2009].
Brieﬂy, the dissociated cells were put into culture plates with serum-
free medium supplemented with mitogens (20 ng/ml EGF, 20 ng/ml
b-FGF, and 10 ng/ml LIF) (Invitrogen, CA, USA). After 7 days, the
formation of neurospheres was observed with a phase-contrast
microscope.
ISOLATION AND CULTURE OF HUMAN GSCs
Human GSCs were isolated from three glioblastoma specimens of
male patients. Brieﬂy, tumor nodules were minced and digested by
0.5% trypsin at 37 °C for 15min. After ﬁltration through 70mm
mesh, the dispersed cancer cells were collected by centrifugation and
then cultured in the same medium as that used for hNSCs above. The
culture media were changed every 3 days. Tumor spheres of different
passages were dissociated into single cells which were then plated
one cell per well. The formation of tumor spheres was observed with
a phase-contrast microscope.
ETHICS STATEMENT
We obtained consents from all participating patients who were
informed and knew the purpose and risk of taking specimens. This
study has been approved by the Medical Ethics Committee of Navy
General Hospital, PLA, Beijing, China. This study was also performed
in strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the Chinese Institutes of
Health. The protocol was approved by the Committee on the Ethics of
Animal Experiments of Navy General Hospital (Permit Number:
0308–2013). All surgery was performed under sodium pentobarbital
anesthesia, and every effort was made to minimize suffering.
IMMUNOFLUORESENCE STAINING TO DETECT THE EXPRESSIONS OF
CD133 AND DIFFERENTIATION MARKERS OF THE GSCs
To characterize the hGSCs, the tumor spheres were transferred to
poly-D-lysine coated chamber slides and cultured in differential
medium of NSCs (DMEM-F12 supplemented with 10% FBS) for
differentiation [Liu et al., 2009]. After 1 and 10-day differentiation,
cells grown on the slides were ﬁxed with 4% paraformaldehyde in
PBS at room temperature for 30min, and permeabilized with 0.1%
Triton X-100 for immunoﬂuorescence staining. The slides were
probed with mouse antibodies against human CD133 (1:1000, Santa
Cruz, CA, USA), human b-Tubulin-III (1:1000, Santa Cruz, CA, USA)
and goat antibody against GFAP (1:1000, BD Bio-science, NY, USA),
at 4 °C, overnight. The secondary antibodies were either FITC- or
RBITC conjugated anti-mouse IgG and anti-goat IgG (1:1000, Santa
Cruz, CA, USA), at room temperature for 30min. The cells were then
counterstained with 40, 60-diamidino-2-phenylindole (DAPI; Santa
Cruz, CA, USA). Images were captured by a laser scanning confocal
microscope (Olympus, Tokyo, Japan).
EXAMINATION OF TUMORIGENICITY OF THE GSCs
To establish intracranial tumors, 1 105cells from the GSC spheres
were implanted into the brains of adult female nude mice by
procedures that were previously described [Liu et al., 2012]. Brieﬂy,
under the guidance of a stereotactic system, 4ml cell suspensionwere
delivered into the right caudate nucleus (2mm lateral and 1mm
anterior to bregma; depth 2.5mm from dura, 0.2ml/min) by injection
JOURNAL OF CELLULAR BIOCHEMISTRY miRNA ALTERNATION IN TRANSITION OF NSCs TO GSCs 1369
through a glass electrode connected to a Hamilton syringe. Nude
mice were sacriﬁced when they becamemoribund or showed signs of
obvious neurological deﬁcit. The frozen sections (10mm) of the
tumors were examined under a ﬂuorescence microscope. The
athymic Balb/c nude mice (female), which weigh from 20 to 25 g,
were phased from the Animal Center of the Chinese Academy of
Medical Science. The mice were maintained in laminar ﬂow cabinets
under pathogen-free conditions and were handled according to the
policies and standards of Laboratory Animal Care in China.
microRNA MICROARRAY
Fluorescent targets were prepared from 2.5mg of total RNA samples
(3 GSCs and 3 NSCs) using miRNA ULSTM Labeling Kit (Kreatech
Diagnostics, The Netherlands). Labeled miRNA targets that were
enriched by NanoSep 100K (Pall Corporation, USA) were hybridized
to the Human miRNA OneArray1v4.0 (HmiOA v4.0 from Phalanx
Biotech Group, Xinzhu, Taiwan) with Phalanx hybridization buffer
using OneArray1Hybridization Chamber. After 16h of hybridization
at 37 °C, non-speciﬁc binding targets were washed away by three
different washing steps (Wash I 37 °C 5min; Wash II 37 °C, 5min;
Wash III 25 °C, 5min). The slideswere then dried bycentrifugation and
scanned by an Axon 4000B scanner (Molecular Devices, Sunnyvale,
CA, USA). The Cy5 ﬂuorescent intensities of each spot were analyzed
by GenePix 4.0 software (Molecular Devices).
The signal intensity of each spot was processed by the R program.
We ﬁltered out spots which the ﬂag<0. Spots that passed the criteria
were normalized by the 75% media scaling normalization method.
Normalized spot intensities were transformed to gene expression
log2 ratios of the control and treatment groups. We have submitted
the data of microRNA array to GEO. The GEO accession number is
GSE 41033 (miRNA proﬁles of brain glioma stem cells and normal
neural stem cells).
HYBRIDIZATION ON HUMAN HOA5.1 ONEARRAY
Cells (3 GSCs and 3 NSCs) were lysed and total RNAwas extracted by
RNeasy Midi kit (Qiagen, Valencia, CA) according to the manu-
facturer’s instructions. The RNA’s integrity and purity were checked
by the electrophoresis of total RNA (Fig. S-1). Then we performed
mRNA expression proﬁling detection using the Human HOA5.1
OneArray (Phalanx Biotech Group, Xinzhu, Taiwan) for three times.
Data was collected and analyzed on the Rosetta Resolved System
(Rosetta Biosoftware, WA, USA). A differentially expressed gene list
was generated by standard selection criteria as established by |Fold
Change| 2 or 0.5, and P< 0.01. We have submitted the data of
mRNA array to GEO, and the GEO accession number is GSE 41031
(Transciptome proﬁles of brain glioma stem cells and normal neural
stem cells).
VERIFICATION OF MICROARRAY DATA WITH qRT-PCR
Total RNA was isolated from cultured GSCs and NSCs using Trizol
reagent (Invitrogen), according to the manufacturer’s instructions,
and assayed by real-time RT-PCR. All primers were designed
according to miRNA and mRNA sequences. A universal PCR reverse
primer was designed using Primer Express version 5.0 (Applied
Biosystems, Foster City, CA) [Chen et al., 2005]. U6small nuclear
RNA gene was used as an internal control [Schmittgen et al., 2004],
and oligonucleotide primers were shown in Table S-1. Real-time
quantitative PCR was performed using standard protocols on an
Applied Biosystem’s 7900HT Sequence Detection System. Brieﬂy,
5ml of template cDNA in water was added to 12.5ml of the 2SYBR
green PCR master mix (Applied Biosystems), and then 2mM MgCl2,
0.5mM of each primer and water were added to 25ml of the 2SYBR
green PCR master mix. The procedures were conducted using Light
Cycler PCR 1.2 (Roche), and Light Cycler FastStart DNAMaster SYBR
Green I(Roche). The ampliﬁcation of selected genes was carried out
as follows: a 3-min hot start at 97 °C followed by 40 cycles of
denaturation at 95 °C for 30 s, annealing at 56 °C for 20 s, and a 72 °C
extension for 30 s. Melting curves were acquired at 75–95 °C, and
samples were also run on a 3% agarose gel to conﬁrm the speciﬁcity.
Each time point included three individual samples in triplicate. Each
assay included a negative control (water instead of template cDNA).
The experiment was done in duplicate.
DATA ANALYSIS OF microRNA AND mRNA
The microRNA expression proﬁling, including data ﬁltering,
normalization and statistical calculations, was processed by Robust
Multichip Average (RMA)./R version 2.12.1. The mRNA arrayslides
were scanned immediately by an Axon 4000B dual channel scanner
(Axon lnstruments, Foster City, CA). The data analysis of gene
expression proﬁling, including data ﬁltering, normalization and
statistical calculations, was processed by Rosetta Resolver1 System
(Rosetta Biosoftware, WA, USA). The Rosetta Resolver1 error model
provides a judgment of the probe signal’s credibility. Both miRNA
and mRNA Arrays of any compared sample set are normalized after
ﬁltering probes according to the ﬂag note from the gpr ﬁles.
BIOINFORMATICS ANALYSIS AND TARGET PREDICTION
Three online software programs, miRanda http://microrna.sanger.
ac.uk, picTar http://www.ncma.org/knowledgeBase/link-database/
mirna target database and targetscan http://www.targetscan.org,
were used for bioinformatics analysis and target prediction for the
miRNAs. We then identiﬁed more reliable miRNA-target relation-
ships using the Pearson analysis and Fisher method. The enrichment
analysis of GO and the KEGG pathway was conducted to study the
regulatory effects of targeted microRNAs. In addition, all the human
genes that have GO annotation were used as background genes, and
the query genes were those differentially expressed genes that had
GO annotation.
TRANSFECTION OF microRNAs MIMICS AND THE USE OF
microRNAs INHIBITORS
We selected hsa-miR-198 for target gene validation, miR-155-5p
and miR-124-3p for functional analysis. MiR-198 inhibitor, miR-
155-5p inhibitor, miR-124-3p mimic and negative controls were
designed and synthesized by GenePharma (Shanghai, China). Cells
were transfected using Lipofectamine 2000 reagent (Invitrogen, CA,
USA). The ﬁnal concentrations of miRNA inhibitors, miRNA mimics
and negative controls were 50 nM.
PROTEIN EXTRACTION AND WESTERN BLOT ANALYSIS
Total protein was extracted by using NP40 lysis buffer (0.5% NP40,
250mM Nacl, 50mM HEPES, 5mM ethylenediamine tetraacetic
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acid, 0.5mM egtazic acid) supplemented with protease inhibitor
cocktails (Sigma, MO, USA). Standard western blotting was
undertaken with monoclonal antibodies against human DCX,
NNAT, GFAP and b-actin proteins (Santa Cruz Biotechnology, CA,
USA) and the corresponding secondary antibodies (Abcam, Camb,
UK). Human b-actin was used as a loading control.
LUCIFERASE ASSAY AND VECTOR CONSTRUCTION
For the luciferase assay, the region predicted to harbor interactor
sites (298–305 bp) of NNAT 30-UTR (NM_181689) were ampliﬁed by
PCR from human genomic DNA and inserted into the pGL3 control
vector (wild-type) (Promega, WI, USA). GSCs were plated in 96-well
dishes at 104 cells/well. Then cells were cotransfected with miR-198
mimic and pGL3 NNAT 30-UTR constructs or scrambled with mutant
pGL3 NNAT 30-UTR constructs. Forty-eight hours after transfection,
cells were incubated for 10min with 20mL/well 1 Passive Lysis
Buffer (Promega, WI, USA). Fireﬂy and renilla luciferase activities
were measured sequentially using dual luciferase assays (Promega)
by a Veritas microplate luminometer (Turner BioSystems, Sunny-
vale, CA). The experiments were performed in quadruplicate in three
independent sets. Values are shown as mean SD.
FUNCTIONAL ANALYSIS FOR HSA-MIR-155-5P AND MIR-124-3P
MiR-155-5p inhibitor and miR-124-3p mimic were used to inhibit
the expression of miR-155-5p and rescue the expression of miR-
124-3p in GSCs respectively. MiR-155-5p inhibitor, miR-124-3p
mimics and negative controls were designed and synthesized by
GenePharma (Shanghai, China). Cells were transfected using
Lipofectamine 2000 reagent (Invitrogen, CA, USA). The ﬁnal
concentrations of miR-155-5p inhibitor, miR-124-3p mimic and
negative controls were 50 nM. For GSCs differentiation, the medium
was replaced with a fresh neural differentiation medium (10% fetal
bovine serum (Gibco, MI, USA) 4 h after treatment. 48 h after
treatment qRT-PCR was performed to identify the altered expres-
sions of miR-155-5p and miR-124-3p. Then, a CCK-8 assay, GFAP
immunoblotting assay and Annexin V staining were undertaken to
study the effects of miR-155-5p and miR-124-3p on GSCs.
For the CCK-8 assay, 2 103 GSCs per well were placed onto a
96-well plate. Then, the cells were transfected with miR-155-5p
inhibitor or miR-124-3p mimic and negative controls for 1 h and
further cultured in the chamber for 24, 48 and 72 h. CCK-8 reagent
was added to the cells 2 h before measuring the optical density (OD)
of 450 nm by a microplate reader according to the manufacturer’s
instructions. Apoptosis wasmeasured in GSCs 48 h after transfection
by means of Annexin V immunostaining and ﬂow cytometry
analysis using the Annexin V-FITC detection kit (BD PharMingen,
San Diego, CA, USA).
RESULTS
ISOLATION AND CHARACTERIZATION OF GSCs
HumanGSCs were isolated and cultured as described in theMaterials
and Methods. After 1 week of primary culture, we obtained tumor
spheres from the GSCs isolated from the GBM tissues (Fig. 1A). These
tumor spheres could be expanded for 10 passages in vitro. Most of
the cells in the tumor spheres are CD133 positive (Fig. 1B). When
these cells were differentiated, GFAP positive astrocytes and
b-tubulin positive neurons could be detected, though the morphol-
ogy of them still remains immature (Fig. 1C). After being implanted
intracranially, these cells could form brain tumors (Fig. 1D).
Together, these data indicate that the CD133 positive cells in the
tumorspheres are GSC-enriched.
DIFFERENTIAL EXPRESSION OF microRNAs AND
GENES IN GSCs VERSUS NSCs
To identify the microRNA programs that may mark the critical
transition of NSCs to GSCs, we compared the microRNA and mRNA
expression proﬁles of GSCs and NSCs using a normalization factor
and clustering. The FC is the ratio of the expression average of case
groups to the expression average of control groups. AmicroRNAwas
deﬁned as differentially expressed when a fold change (FC) 1.5 or
less than 1/1.5, and a value of P< 0.05 was obtained. We found that
116 microRNAs were up-regulated and 62 microRNAs were down-
regulated in GSCs compared to NSCs. The top 10 up-regulated
microRNAs and top 10 down-regulated microRNAs are shown in
Table I (The expression values of these microRNAs were shown in
Table S-2). Among them, the FC value of miR-155-5p in GSCs is
>9 times higher than that in NSCs. In contrast, the FC value of miR-
124-3p in GSCs is <1/60 of that in NSCs. Both have been shown to
play important roles in the development of tumors (Lang et al., 2012;
Silber et al., 2013). MicroRNA hierarchical clustering was generated
for both up-regulated and down-regulated miRNAs with fold-
changes greater than 1.5 or less than 1/1.5. The hierarchical
clustering image of miRNAs is shown in Figure S-2. In contrast to
NSCs, we found 1501 genes up-regulated, and 1372 genes down-
regulated in GSCs based on the selection criteria that FC> 2 or
FC< 1/2, and a value of P< 0.01. We showed the top 10 of
differentially expressed genes in GSCs in Table II (The expression
values of these genes were shown in Table S-2). A subset of
differentially expressed genes was selected for clustering analysis.
For this microarray project, the number of genes clustered was 2873.
The hierarchical clustering image of the genes is shown in Figure S-3.
Using GO enrichment analysis carried out on the ranked list of
mRNAs, we were able to elucidate the biological modules that are
correlated or anti-correlated to the expression level of the pivot
miRNA. This association indicates the biological process in which
the pivot miRNA plays a role. According to the analysis of GO and
KEGG pathways, several pivot miRNAs showed a strong association
with the development of glioma, such as axon guidance, cell cycle,
cell adherence and apoptosis et al. (Fig. 2).
SCREENING THE RELATIONSHIPS OF microRNAs AND TARGETS
To further examine the function of those signiﬁcantly altered
miRNAs (116 up-regulated and 62 down-regulated) in GSCs
compared with NSCs, we proceeded to searching the target genes
of miRNAs associated with GSCs. Based on the differential
expressions of miRNAs and mRNA targets as described above, we
analyzed the relationships of miRNA-targets using the databases of
miRanda, Targetscans and Pictar. We found 947 relationships,
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involving 29 miRNAs and 844 protein-coding genes (Table S-3).
Among them, the relationships of hsa-miR-1-GNPDA2 and hsa-
miR-1-CLCN3 have been clariﬁed [Lim et al., 2005; Goljanek et al.,
2012]. We calculated the regulation extent of the miRNA-target
using u value. The formula is u¼ (jFC1–1/FC2j) (FC1: up-regulated
gene or microRNA, FC2: thedown-regulated microRNA or gene,
which is relative to the up-regulated genes andmicroRNA). Using the
u values, we obtained the top 10 differently expressed miRNA-target
relationships, which are shown in Table III.
REAL-TIME RT-PCR OF microRNAs AND GENES
To conﬁrm the identiﬁcation of these differentially expressed
microRNAs and genes, we used real-time RT-PCR to detect the
expression levels of six microRNAs (hsa-miR-198, hsa-miR-137,
hsa-miR-653, hsa-miR-146b-5p, hsa-miR-152, and hsa-miR-125a-
3p) and seven target genes of these miRNAs (DCX, PTGS2, SCGN,
GAD2, OTX2, PEG10, and NRXN3), which were found to have
signiﬁcant inverse correlation (Table III). All primers were designed
based on miRNA and mRNA sequences. U6 small nuclear RNA gene
and b-actin gene were used as internal controls. The Ct value is the
fractional cycle number at which the ﬂuorescence generated by the
reporter dye exceeds a ﬁxed level above the baseline. The selected
genes’ signals were normalized against the relative quantity of U6
and expressed as DCt¼ (Ct selected geneCt U6). The change in
selected genes’ signals relative to the reference signal (control
sample) was expressed as DDCt ¼ (DCt controlDCt sample). The
relative changes in expression were then calculated as 2[DD Ct]. Five
of the six selected microRNAs and all of the seven selected genes
were differentially expressed between the hNSCs and hGSCs
analyzed in this study, and concordant with the microarray data,
with miR-653 being the only exception (Table S-4). The ampliﬁca-
tion curves and melting curves in the PCR reactions and the statistic
bar charts are shown in Figure 3. As shown in Figure 3C, the
concordance rate of miRNA array and qRT-PCR is 83.33%, and the
concordance rate of mRNA and qRT-PCR is 100% (Figure 3F).
VALIDATION OF DIRECT TARGET OF MIR-198
Among the top 10 differently expressed microRNA-target relation-
ships (Table III), we selected miR-198 and its predicted targets (DCX
and NNAT) to validate. We analyzed the expression alterations of
Fig. 1. Characterization of hGSCs. A) After culture in vitro for 7 days, hGSCs formed neurosphere (20). B) The spheres of GSCs were transferred to poly-D-lysine coated
chamber slides and cultured in DMEM-F12 supplemented with 10% FBS. After 24 h of culture, the tumor spheres were stained with mouse antibody against human CD133. Most
of the tumor cells in the sphere were CD133 positive (Green) (40). C) After differentiation, the slides were probed with goat antibody against human GFAP and mouse antibody
against human b-Tubulin. GFAP immunoreactive positive astrocytes (Red) and b-Tubulin immunoreactive positive neurons (Green) were observed (40). D) 1 105 tumor cells
from the GSC spheres were implanted into the brains of adult female nude mice by a stereotactic system. One month later, HE staining showed that the GSCs formed neoplasm
(40). In the picture, tumor margin was indicated by “>”, and the tumor tissue was indicated by “T”, while normal brain tissue was indicated by “N”. The above experiments were
repeated three times respectively.
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DCX and NNAT proteins by western blot 48 h after knocking-down
ofmiR-198 in GSCs. Results showed that NNAT expression increased
signiﬁcantly aftermiR-198 knocking-down, but DCX did not change
expressively (Fig. 4A). Furthermore, regulation of NNAT bymiR-198
was conﬁrmed by luciferase assay. The results showed that the
reporter plasmid with wild-type 30-UTR of NNAT caused a
signiﬁcant increase in luciferase activity in GSCs transfected with
miR-198 inhibitor, whereas mut-type 30-UTR of NNAT produced no
change in luciferase activity (Fig.4B). Taken together, these data
indicate that miR-198 directly modulates NNAT expression by
binding to 30UTR of NNAT.
FUNCTION ANALYSIS FOR HSA-MIR-155-5P AND MIR-124-3P
Hsa-miR-155-5p and miR-124-3p, which increased and decreased
respectively most noticeably in GSCs compared to NSCs, were
selected for functional analysis. To determine whether the abnormal
TABLE I. The Top 10 Up-Regulated and Top 10 Down-Regulated microRNAs in GSCs
microRNA FC P-value q-value
Up-regulated microRNAs hsa-miR-155–5p 9.46093 0.002279 0.107965
hsa-miR-1247–3p 6.910358 0.009639 0.167936
hsa-miR-513a-5p 6.589985 0.01189 0.177153
hsa-miR-4299 6.06227 0.000807 0.086871
hsa-miR-513b 5.9837 0.004612 0.126887
hsa-miR-4653–3p 5.969425 4.38E03 0.126134
hsa-miR-652–5p 5.909472 0.001623 0.107754
hsa-miR-642a-3p 5.822695 0.001824 0.107754
hsa-miR-30c-1–3p 5.745478 0.005078 0.127089
hsa-miR-1275 5.565442 6.62E06 0.006854
hsa-miR-124–3p 0.016607 0.003935 0.125472
Down-regulated microRNAs hsa-miR-7-5p 0.206311 0.012752 0.178109
hsa-miR-3148 0.315938 0.005779 0.135649
hsa-miR-135b-5p 0.338157 0.005778 0.135649
hsa-miR-3650 0.343757 0.015203 0.193413
hsa-miR-181c-5p 0.398294 0.008941 0.164242
hsa-miR-153 0.404268 0.01983 0.216071
hsa-miR-147a 0.416814 0.000382 0.065449
hsa-miR-128 0.418377 0.037754 0.276778
hsa-miR-4999–5p 0.440248 0.002895 0.107965
A microRNA was deﬁned as differentially expressed when fold change (FC) 1.5 or 1/1.5, and a value of p< 0.05 was obtained. We found that 116 microRNAs were
upregulated and 62 microRNAs were downregulated in GSCs compared to NSCs.
TABLE II. The Top 10 Up-Regulated and Top 10 Down-Regulated Genes in GSCs
Gene Symbol Gene Description FC P-value q-value
Up-regulated genes IGFBP3 insulin-like growth factor binding protein 3 1354.4 1.54E05 0.00075
PTGS2 prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase
and cyclooxygenase)
581.1269 1.28E03 0.006886
NNMT nicotinamide N-methyltransferase 451.7361 1.45E-06 4.28E04
PRORSD1P prolyl-tRNA synthetase associated domain containing 1, pseudogene 385.9963 2.30E06 0.000439
CP ceruloplasmin (ferroxidase) 166.5336 0.001636 0.00805
CHI3L2 chitinase 3-like 2 165.5163 1.86E04 0.00231
TNFAIP6 tumor necrosis factor, alpha-induced protein 6 129.5437 0.002093 0.00947
HOXB7 homeobox B7 121.1777 1.39E03 0.007222
CASP4 caspase 4, apoptosis-related cysteine peptidase 115.2229 1.24E-04 0.001853
BIRC3 baculoviral IAP repeat containing 3 102.3944 5.35E05 0.00129
NPY neuropeptide Y 0.000239 0.001885 0.008842
Down-regulated genes SST somatostatin 0.001367 1.53E06 0.000428
DCX doublecortin 0.001761 6.29E07 0.000306
GAD2 glutamate decarboxylase 2 (pancreatic islets and brain, 65 kDa) 0.003766 1.99E03 0.009154
INA internexin neuronal intermediate filament protein, alpha 0.004196 6.31E07 0.000306
SLC32A1 solute carrier family 32 (GABA vesicular transporter), member 1 0.004403 0.000254 0.00269
SOX1 SRY (sex determining region Y)-box 1 0.004933 2.51E06 0.00044
MEG3 maternally expressed 3 (non-protein coding) 0.005550 0.000564 0.004202
PEG10 paternally expressed 10 0.005780 6.74E06 0.000565
NRXN3 neurexin 3 0.006088 2.06E05 0.000848
We found 1,501 genes up-regulated, and 1,372 genes down-regulated in GSCs based on the selection criteria that FC>2 or FC< 1/2, and a value of p< 0.01.”
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expressions of miR-155-5p and miR-124-3p could inﬂuence GSCs
proliferation, differentiation and apoptosis, experiments with
miR-155 knockdown and miR-124-3p overexpression in GSCs
were conducted.
To show the effects of miR-155-5p inhibitor and miR-124-3p
mimic, we used qRT-PCR to test the altered expressions of miR-155-
5p andmiR-124-3p. Treatment withmiR-155-5p inhibitor decreased
the expressions of miR-155-5p, while treatment with miR-124-3p
Fig. 2. Representative enriched GO BP and KEGG pathways of the down-regulated and up-regulated genes. A) The top 10 enriched GO BP of the down-regulated genes. Among
the 1372 down-regulated genes, there are 139 enriched GO BP with FDR< 0.01. The top 10 are shown. B) The relevant pathways of the down-regulated genes. In the down-
regulated genes, there are 5 KEGG pathways with FDR< 0.01. They are associated with oocyte meiosis, axon guidance, cell cycle, and other pathways in cancer and progesterone-
mediated oocyte maturation. C) The top 10 enriched GO BP of the up-regulated genes. Among the 1501 up-regulated genes, there are 62 GO BP enriched, with FDR< 0.01. The
top 10 are shown.
TABLE III. The Top 10 Differently Expressed microRNA-Target Relationships
microRNA Gene Symbol microRNA FC Gene FC u
hsa-miR-198 DCX 2.985085 0.012328 84.10374
hsa-miR-137 PTGS2 0.700126 0.012133 83.85098
hsa-miR-198 NNAT 4.844031 0.01567 68.65864
hsa-miR-653 SCGN 1.281046 0.019109 53.61334
hsa-miR-653 GAD2 1.281046 0.02088 49.17327
hsa-miR-146b-5p OTX2 2.377223 0.025847 41.06623
hsa-miR-152 OTX2 1.738666 0.025847 40.42767
hsa-miR-653 PEG10 1.281046 0.028099 36.86888
hsa-miR-125a-3p NRXN3 1.996175 0.029129 36.32679
hsa-miR-653 NRXN3 1.281046 0.029129 35.61166
u ¼ (jFC1–1/FC2j) (FC1: upregulated gene or microRNA, FC2: the downregulated microRNA or gene, which is relative to the upregulated genes and microRNA)
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mimic increased the expression of miR-124-3p signiﬁcantly
compared to the treatment with negative controls (Fig. 5).
For function analysis, the effects of miR-155-5p and miR-124-3p
were assessed by experiments with CCK-8 assay, GFAP immuno-
blotting and Annexin V staining. The results showed that both
miR-155 inhibitor and miR-124-3p mimic were able to reduce the
proliferation of GSCs signiﬁcantly (Fig. 6). However, increased
expression of GFAP was observed after miR-155-5p inhibitor
treatment (Fig. 7), whereas, an increased number of Annexin V-FITC
positive cells was observed in the group of miR-124-3p mimic
treatment (Fig. 8). Collectively, these data suggest that miR-155-5p
has a potential promoting role while miR-124-3p has an inhibiting
role in the malignant development of GBM derived stem cell-like
cells.
DISCUSSION AND CONCLUSIONS
Recent studies have shown that glioma may arise from GSCs that
result from transformed NSCs [Bachoo et al., 2002; Alcantara et al.,
2009; Holland et al., 1998]. Several studies have examined the
expressions, targets and functional effects of selected miRNAs in
Fig. 3. Q-RT-PCR veriﬁcation of miRNA and mRNA expression. The ampliﬁcation curves and melting curvets in the PCR reactions were clear (A and B, D and E). C) Six miRNAs
were compared between GSCs and NSCs by Q-RT-PCR. Five of the six miRNAs tested by real-time RT-PCR gave results consistent with the microarray data, except for miR-653,
indicating a concordance rate of 83.33%. F) Seven genes were compared between GSCs and NSCs by Q-RT-PCR. All genes tested by real-time RT-PCR gave results consistent with
the microarray data, indicating a concordance rate of 100%.
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glioma cells and tissues [Wang et al., 2012; Yu et al., 2012]. However,
the differences between GSCs and NSCs in expression proﬁles of
miRNAs and mRNAs have not been fully identiﬁed. In this study, we
conducted a global analysis of bothmiRNA andmRNA expression in
human GSCs and NSCs, and further analyzed the miRNA data and its
matching mRNA data jointly for the ﬁrst time. Taking a systematic
approach to joint analysis will enhance our understanding of the role
ofmiRNA in glioma pathogenesis and progression. In this report, 178
miRNAs were shown to have distinct expressions in GSCs vs. in
NSCs, and 2873 mRNA expressions were altered signiﬁcantly in
GSCs compared to those in NSCs (Table S-2). In screening the
relationships of miRNAs and mRNA targets, we obtained 947
relationships, involving 29 miRNAs and 844 protein-coding genes
(Table S-3), and identiﬁed the top 10 differently expressed miRNA-
target relationships using u value (Table III). The results of Table III
showed that miR-198 is signiﬁcantly upregulated in GSCs, and has
higher u values with its target genes (DCX andNNAT). Recently,miR-
198 was found overexpressed in esophageal cancer (Qi et al., 2013).
Furthermore, the direct target genes of miR-198 were validated by
western blot and luciferase activity assay. Though both DCX and
NNAT were predicted as target genes of miR-198, our results of
western blot and luciferase activity assay showed that NNAT, but not
DCX, is the direct target gene of miR-198 (Fig. 4A & 4B). Recent
evidence indicated that NNAT expresses in GSCs and is associated
with signiﬁcant increase in cellular proliferation (Xu et al., 2012). In
addition, Among the top 10 differently expressed miRNA-target
relationships, miR-653, miR-146b-5p, miR-152, miR-155-5p, miR-
125a-3p and miR-198 were found to be negatively correlate to their
targeting mRNA, such as PDGF, STAT3, PTEN and OLG [Zhu
et al., 2005; Kesari et al., 2006; Zheng et al., 2008; Sherry et al.,
Fig. 4. Effects of miR-198 on expressions of DCX and NNAT. A)Western blot analysis showed that the expression levels of NNAT protein in the miR-198 inhibitor (miR-198 I)-
treated group was signiﬁcantly higher than in the control. B) miR-198 I increased the luciferase activity of a reporter containing the 30UTR of NNAT (P< 0.001), whereas miR-
198 could not increase the luciferase activity of the same reporter containing a mutated sequence of 30UTR of NNAT.
Fig. 5. miR-155-5p and miR-124-3p expressions after treatment with
negative controls (NC), miR-155-5p inhibitor or miR-124-3p mimic in GSCs
analyzed by qRT-PCR. A) MiR-155-5p expression in miR-155-5p inhibitor
treated cells was signiﬁcantly lower than in untreated cells (24 h-B, blank
control) and negative control treated cells (24 h-NC, negative control)
(*P< 0.05). B)MiR-124-3p expression inmiR-124-3pmimic treated GSCswas
signiﬁcantly higher than in untreated cells(24 h-B) and negative control treat
cells(24 h-NC) (*P< 0.01). The results are the mean SD of triplicate
experiments.
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2009], which are important stem cell regulators (Table S-3). Hsa–
miR-125a-3p, hsa–miR-152 and hsa–miR-198 showed an associa-
tion with cell cycle genes, such as CDKN2B, PTEN, PIDD and
DLGAP5; whereas hsa–miR-146b-5p and hsa–miR-152 also showed
an associationwith cell adhesion genes, such as CADM2 and NCAM1
(Table S-3). A major shift in the cell cycle rate, cell apoptosis and cell
adhesion is required for the transformation from NSCs to rapid
cycling and highly invasive GSCs, so these miRNAs are important in
the malignant transformation from NSCs to GSCs and the predicted
miRNA-target relationships may provide useful information for
further studies of origin and development of glioma.
Furthermore, the functional enrichment analysis of each
differential expressed miRNAs between GSCs and NSCs was
undertaken using GO and KEGG software online. A set of associated
miRNAs (miR-1, miR-30e-5p, miR-107, miR-129-5p, miR-137, miR-
153, miR-198, miR-199b-5p, miR-361-5p, miR-496, miR-128, miR-
125a-3p, miR-146b-5p and miR-152) were identiﬁed in this study,
whose target genes were found to have at least one functional
enrichment, such as cell cycle, axon guidance, adhesion junction,
MAPK signaling, and wnt signaling (Table S-2). Among them, miR-
128, which was found to be signiﬁcantly down-regulated in GSCs,
was reported to regulate oncogenic transformation and stem cell-
like behavior in immortalized nontumorigenic mammary epithelial
cells partly by regulating the PI3K/AKT and STAT3 signaling
pathways [Peng et al., 2012]. MiR-125a-3p, which was found to be
signiﬁcantly higher in GSCs than in NSCs, was reported to regulate
the migration and invasion of tumors by mediating CCL, IGF-2 and
wnt signaling [Lili et al., 2010; Alhua et al., 2012]. Both miR-146b-
5p and miR-152 are signiﬁcantly higher in GSCs than in NSCs, and
have been found to take part in cell adhesion and regulate glioma cell
invasion and angiogenesis by attenuating the expression of MMP-3
[Katakowski et al., 2010]. It is likely that some of the programs that
Fig. 6. The effect of miR-155-5p and miR-124-3p on the proliferation of
GSCs. Both miR155 knockdown and miR-124 overexpression signiﬁcantly
reduced the proliferation of GSCs in vitro measured by CCK8 assay (A & B).
Cell growth was monitored every 24 h. Absorbance at 0 h was assigned a value
of 1. B: blank control (untreated cells), NC: negative controls. The results are
the mean SD of three replicates. *P< 0.01.
Fig. 7. The effect of miR-155-5p andmiR-124-3p on the differentiation of GSCs. A) The expression of GFAP increased signiﬁcantly in GSCs 48 h after treatment with miR-155
inhibitor detected by Western blot, while the expression of GFAP revealed no obvious changes after miR-124 mimic treatment. B) The semi-quantitative analysis of GFAP
expression. NC: negative controls. The results are the mean SD of three replicates. *P< 0.01.
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regulated by these miRNAs are associated with the transition from
NSCs to GSCs. These miRNAs and their target genes that
differentially expressed between GSCs and NSCs may represent
important candidates for further characterization of the pathogene-
sis and development of glioma.
In addition, among 178 miRNAs, the expressions of miRNA-155-
5p and miRNA-124-3p were found to be altered most noticeably, so
these two miRNAs were selected for functional analyses. We found
that miR-155-5p could induce differentiation and inhibit prolifera-
tion of GSCs, whereas miR-124-3p could promote apoptosis and
growth rest of GSCs (Figs, 6, 7, 8 5). These functional studies of
miRNAs provide direct evidence that miR-155-5p and miR-124-3p,
which demonstrated signiﬁcant abnormal expressions in GSCs
compared to NSCs, can modulate GSCs biological behaviors. These
results support the conclusion that miR-155-5p plays a promoting
role, whereas miR-124-3p plays an inhibitory role in the malignant
transformation from NSCs to GSCs. Lang et al. compared the
microRNA proﬁle between GSCs and NSCs and also found that the
expression of miR-124 signiﬁcantly decreased and the expression of
miR-193a-3p increased in GSCs compared to NSCs. However, they
did not conduct global analysis of mRNA expression in human GSCs
and NSCs and did not further characterize the functional roles of
thesemiRNAs in GSCs [Lang et al., 2012]. In this study, we found that
the expression of miR-155-5p in GSCs was nine times higher than its
expression in NSCs, and miR-147 and miR-124-3p were signiﬁcant-
ly lower in GSC than in NSC. These results suggested that these
miRNAs might play important roles in the transition process of NSCs
to GSCs. Bioinformation analysis showed that one of the predicted
targets for miRNA-155-5p is bone morphogenetic protein (BMP).
Interestingly, it has been shown that BMPs could regulate the
proliferation and differentiation of GSCs in several previous studies
[Piccirillo et al., 2006; Lee et al., 2008]. Furthermore, Qinyan et al.
reported that miR-155 targets the 30 untranslated region (30-UTR) of
multiple components of the BMP signaling cascade, and results in
the inhibition of BMP-mediated induction of p21, and reverses BMP-
mediated cell growth inhibition [Qinyan et al., 2010]. We also found
in our previous study [Liu et al., 2009] that the BMP signaling
pathway could regulate the differentiation and proliferation of
malignant glioma cells. In contrast, MiR-147 has been identiﬁed as a
novel tumor suppressor that co-targets EGFR-driven cell cycle
network proteins and inhibits cell-cycle progression and prolifera-
tion in breast cancer [Geraldo et al., 2012]. The reduced expression of
miR-124 in GSCs is also consistent with its inhibitory function in the
development of many tumors. Silber reported that miR-124 inhibits
the expression of CDK6 and prevents the proliferation of
glioblastoma and medulloblastoma cells in vitro [Silber
et al., 2013]. Together, our ﬁndings in this report may provide
additional information regarding the roles played by the miRNAs in
the origin and development of glioma.
Among the 2873 mRNAs, the Nicotinamide N-methyltransferase
(NNMT) was observed to be signiﬁcantly higher in GSCs than in
NSCs in this study. NNMT has shown a very high level of expression
in other cancer cell lines, and the knockdown of NNMT could
efﬁciently suppress cell proliferation and decrease colony formation
[Pozzi et al., 2011]. So, the aberrant increase of NNMT in GSCs may
also be associated with GSCs development. In contrast, SRY (Sex
determining region Y)-box1(Sox1) was found to be signiﬁcantly
lower in GSCs than in NSCs. In this study, such factor as sex should
not be considered because both human GSCs and human NSCs were
derived from male patients, so, the deletion or decrease of Sox1 in
GSCs may contribute to the malignant transition of NSCs to GSCs.
Sox1 has been reported to be frequently down-regulated through
promoter hypermethylation in hepatocellular carcinoma (HCC) cells
and tissues. The over-expression of Sox1 could suppress cell
proliferation, colony formation, and invasion ability in HCC cell
lines [Tsao et al., 2012].
Fig. 8. The effect of miR-155-5p and miR-124-3p on the apoptosis of GSCs. Statistical analysis of the percentages of viable apoptotic cell (VA), viable non-apoptotic cell
(VNA), non-viable non-apoptotic cell (NVNA) or non-viable apoptotic cell (NVA). B: blank control (untreated cells), NC: negative controls.
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It is of note that the expressional alterations of some miRNAs and
mRNAs and their function roles are found contrary to their
functional roles reported in some previous studies. MiR-210 was
signiﬁcantly lower in GSCs than in NSCs, which is at odds with its
survival promotion effects in mesenchymal stem cell (MSCs) [Yu
et al., 2011]. In addition, the insulin-like factor binding protein-3
(IGFBP3), which was found noticeably increased in GSCs, has been
reported to be a multi-functional protein that is known to induce
apoptosis of various cancer cells by the activation of caspases and
the induction of cell cycle arrest [Wu et al., 2013]. These observations
suggest that the same miRNA and mRNA can have distinctly
different biological activities under different cellular contexts.
Although somemiRNAs and genes have been studied in other cancer
cells previously, none of them has been studied in glioma. Thus, they
should be further characterized for their regulatory roles in various
aspects of GSC biology.
In summary, this study revealed broad differences in miRNA
proﬁles between humanGSCs and NSCs. Our results strongly suggest
that miRNA-controlled post-transcriptional programs modulate
extensive networks that deﬁne the functional properties of the
transition of NSCs to GSCs. Global miRNA and mRNA expression
proﬁles may distinguish between normal NSCs and GSCs and help
with the discovery of the origin and development of glioblastoma.
Clinically, these miRNAs may serve as therapeutic targets and
diagnostic and prognostic tools for the management of malignant
gliomas.
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